跳至主要内容
临床试验/TCTR20200121002
TCTR20200121002已完成2 期

Clinical Outcome in patient with cerebral vasospasm after aneurysmal subarachnoid hemorrhage treated with intra-arterial Nimodipine infusion: A Randomized Controlled Trial

one0 个研究点目标入组 68 人开始时间: 2020年1月21日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
one
入组人数
68

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • ASAH patients, ranging in age 18 - 80 years, on whom aneurysm obliteration was performed, either by surgical clipping or endovascular therapy
  • After aneurysm obliteration, digital subtraction diagnostic angiography was performed on all patients. If angiographic vasospasm was demonstrated, we enrolled the patients, whether or not they suffered any clinical vasospasm, such as alteration of consciousness, new motor deficits, or unexplained fever. Consent was informed and obtained from the patients or their relatives, as appropriate
  • Every angiography was done within 14 days, according to the date of rupture, otherwise the case was excluded. After we found any angiographic vasospasm (defined as any acute tapering or focal vasoconstriction of any vessels compared to prior diagnostic imaging), we categorized patients into good neurological baseline group, defined as World Federation of Neurological Surgeons’ score (WFNS) grade I-III, and poor neurological baseline group defined as WFNS grade IV-V first, and then performing block randomization into 1:1 of the intervention and control groups

排除标准

  • No angiographic vasospasm
  • Angiography done after 14 days
  • Denied consent

研究者

发起方
one

相似试验